# Effectiveness and Tolerability of Eqwilate in Real-life Conditions

> **NCT04106908** · — · ACTIVE_NOT_RECRUITING · sponsor: **Octapharma** · enrollment: 38 (actual)

## Conditions studied

- VWD - Von Willebrand's Disease

## Interventions

- **BIOLOGICAL:** Eqwilate

## Key facts

- **NCT ID:** NCT04106908
- **Lead sponsor:** Octapharma
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-11-27
- **Primary completion:** 2024-05-11
- **Final completion:** 2026-11
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2025-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04106908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04106908, "Effectiveness and Tolerability of Eqwilate in Real-life Conditions". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04106908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*